Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Discover effective wealth growth strategies for beginners that pave the way to financial success. Start learning and investing wisely now.
23,833 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
A major investment manager recently disclosed a sizable position in Varonis Systems. This article unpacks what the mo...
In a volatile AI market, SoundHound AI posts a narrower loss for Q4 2025 and lifts 2025 revenue guidance, underscorin...
Stratasys has long been a trailblazer in 3D printing, but the road ahead is proving tougher amid competition and cost...
MercadoLibre stock slid 17% in the past month as JPMorgan cut its target to $2,100, citing fierce competition and mar...
As AI drives demand for faster memory, Micron sits at the center of a cyclical industry that can fuel outsized moves....
As AI demand accelerates, one company stands out for investors: TSMC. This article explains why the so-called tsmc mo...
SoundHound posted revenue gains for the quarter, yet earnings slipped as acquisition-related costs weighed on results...
Nokia stock jumped today as investors cheered a fresh AI-driven approach to network management. The move hints at a b...
Century DeAnna Realty capped a five-year growth sprint with a 110% rise in transactions, leveraging culture-driven M&...
Marvell Technology shares surprised investors with a notable intraday uptick amid improving sentiment for semiconduct...
A Nike brand moat argument resurfaces as investors weigh the stock's downside and potential upside. A Nike analyst po...